Discover
Stocks
Healthcare
MRK
MRK
Merck & Co.
105.63
-0.60
(
-0.56%
)
Market Closed
Delayed Prices By NASDAQ,
in USD
Trade
Buy
MRK
Merck & Co.
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Merck & Co.'s revenues increased by 21.72% and amounted to 59.28B. Net income increased by 17.54% to 14.53B. Net assets decreased by NaN to N/A and EPS increased from 5.14 to 5.71.
MRK's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
70.27%
Net Profit Margin
19.35%
Operating Margin
13.83%
Return On Investment
15.75%